PLAT and Stroke: Success in the treatment of ischemic stroke seen with the use of intravenous tissue plasminogen activator (TPA) in the National Institute of Neurological Disorders and Stroke (NINDS) trial was measured at 3 months, not immediately.[2–6] Patients who make a more rapid recovery might have been experiencing a reversible ischemic neurologic disorder (RIND).